[PDF] Top 20 Un Análisis sobre las Políticas de Integración Productiva en el MERCOSUR

... that trabectedin depends on the status of both nucleotide excision repair (NER) and homologous recombination (HR) DNA repair pathways [8 – ...to trabectedin than their NER- proficient counterparts [8, 9, ... See full document

... metastatic soft tissue sarcoma have a poor outlook with median survival in the order of 1 ...disease. Trabectedin is one such novel agent that has demonstrated activity for patients with ... See full document

... as trabectedin, into the therapeutic armamentarium of STS underlines the complexity and potential importance of immunogenicity and microenviron- ment interactions in the pathogenesis of ...tumor activity of ... See full document

... LGFMS, also known as Evans tumor, usually occurs in deep soft tissue, and is characterized by a very bland histological appearance. The translocation t(7;16)(q33;p11) so far seems to be specific for LGFMS ... See full document

... histology (NOS). Two-thirds (66%) of the patients had high grade sarcomas. Nearly 20% of the patients had metastatic disease at the time of diagnosis. All 101 histological specimens of STS were stained for ... See full document

... Crizotinib (PF-02341066; Pfizer) is a selective anaplas- tic lymphoma kinase (ALK) kinase inhibitor with additional activity against c-MET tyrosine kinase. Crizotinib was recently granted accelerated FDA ... See full document

... retroperitoneal soft-tissue sarcomas reflect intra- and inter-tumor ...other soft-tissue ...retroperitoneal soft-tissue sarcomas and significant individual ... See full document

... proteins behave as a scaffold to bridge TLE1 and the DNA-binding protein activating transcription factor 2 (ATF2) [41]. The physiologic role of ATF2 as a master transcriptional activator is reversed in the ... See full document

... Background: Soft tissue sarcomas comprise less than 1% of all solid malignancies. The presentation and behavior of these tumors differs depending on location and histological characteristics. ... See full document

... grade sarcomas after combined surgery and postoperative brachytherapy compared with surgery ...grade sarcomas did not benefit from adjuvant brachytherapy, although a recent effectively decreased local ... See full document

... doxorubicin monotherapy was considerably shorter in duration than maintenance treatment after combination therapy (median of four versus nine cycles) 2 . Of note, crossover to olaratumab monotherapy after disease ... See full document

... Trabectedin has several modes of action. Unlike clas- sical alkylating chemotherapeutic drugs, which bind to the major DNA groove, trabectedin binds to specific selected triplets of the DNA minor groove. ... See full document

... Abstract: Accumulated evidence has indicated a correlation between IGF-1R and bone and soft tissue sarcoma (BSTS) progression. However, research on the prognostic role of IGF-1R in sarcomas has ... See full document

... with trabectedin in a consecutive series of pretreated ...with trabectedin were also analyzed accord- ing to ECOG PS, age, histology, sex and line of therapy, and ... See full document

... Introduction: Soft tissue sarcoma accounts for less than 1% of all malignant neoplasms and is comprised of a very heterogeneous group of tumors with over 50 different ...disease. Trabectedin ... See full document

... Soft-tissue sarcoma (STS) is a rare form of cancer that develops in connective tissues. Approximately 3,300 new cases are diagnosed every year in the UK and the 5-years survival rate is ∼ 53% (1). STS ... See full document

... Ewing’s sarcomas (ESs) and osteosarcomas (OSs) and is now considered an inalienable part of the treatment paradigm of these diseases, the role of adjuvant chemo- therapy in adults with non-RMS, non-ES and non-OS ... See full document

... unresectable sarcomas that would otherwise require an amputation, although if the tumour subsequently remains inoper- able the durability of response is ... See full document

... iv rucaparib at RP2D as established in stage 1 and were stratified in four groups according to the type of BRCA mutations (BRCA 1 or 2) and the tumor type (breast or ...improved activity. After oral ... See full document

... Our results indicate that MLN-8237 is highly active against multiple sarcoma subtypes in low nanomolar concentrations even in the absence of Aurora A amplification. Though described as an Aurora A inhibitor, our ... See full document